Sol-Gel Technologies (SLGL) Competitors $0.76 -0.09 (-10.69%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLGL vs. BMEA, ABOS, RENB, INZY, VTVT, RANI, ANRO, MGX, ADAP, and VHAQShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Biomea Fusion (BMEA), Acumen Pharmaceuticals (ABOS), Renovaro (RENB), Inozyme Pharma (INZY), vTv Therapeutics (VTVT), Rani Therapeutics (RANI), Alto Neuroscience (ANRO), Metagenomi (MGX), Adaptimmune Therapeutics (ADAP), and Viveon Health Acquisition (VHAQ). These companies are all part of the "pharmaceutical products" industry. Sol-Gel Technologies vs. Biomea Fusion Acumen Pharmaceuticals Renovaro Inozyme Pharma vTv Therapeutics Rani Therapeutics Alto Neuroscience Metagenomi Adaptimmune Therapeutics Viveon Health Acquisition Sol-Gel Technologies (NASDAQ:SLGL) and Biomea Fusion (NASDAQ:BMEA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk. Does the media prefer SLGL or BMEA? In the previous week, Biomea Fusion had 3 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 5 mentions for Biomea Fusion and 2 mentions for Sol-Gel Technologies. Biomea Fusion's average media sentiment score of 1.18 beat Sol-Gel Technologies' score of 0.44 indicating that Biomea Fusion is being referred to more favorably in the news media. Company Overall Sentiment Sol-Gel Technologies Neutral Biomea Fusion Positive Do insiders and institutionals have more ownership in SLGL or BMEA? 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 96.7% of Biomea Fusion shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by insiders. Comparatively, 27.6% of Biomea Fusion shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor SLGL or BMEA? Sol-Gel Technologies received 88 more outperform votes than Biomea Fusion when rated by MarketBeat users. However, 68.54% of users gave Biomea Fusion an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformSol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Biomea FusionOutperform Votes6168.54% Underperform Votes2831.46% Which has preferable valuation and earnings, SLGL or BMEA? Sol-Gel Technologies has higher revenue and earnings than Biomea Fusion. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Biomea Fusion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSol-Gel Technologies$11.71M1.81-$27.24M-$0.34-2.24Biomea FusionN/AN/A-$117.25M-$3.84-0.55 Do analysts rate SLGL or BMEA? Sol-Gel Technologies presently has a consensus target price of $5.00, suggesting a potential upside of 557.89%. Biomea Fusion has a consensus target price of $23.91, suggesting a potential upside of 1,038.53%. Given Biomea Fusion's higher possible upside, analysts plainly believe Biomea Fusion is more favorable than Sol-Gel Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Biomea Fusion 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more volatility and risk, SLGL or BMEA? Sol-Gel Technologies has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500. Comparatively, Biomea Fusion has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500. Is SLGL or BMEA more profitable? Biomea Fusion has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat Biomea Fusion's return on equity.Company Net Margins Return on Equity Return on Assets Sol-Gel Technologies-81.75% -27.17% -22.49% Biomea Fusion N/A -118.90%-93.66% SummaryBiomea Fusion beats Sol-Gel Technologies on 9 of the 17 factors compared between the two stocks. Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.17M$6.89B$5.57B$7.83BDividend YieldN/A3.06%5.11%4.21%P/E Ratio-2.247.4422.4418.48Price / Sales1.81242.73394.10103.59Price / CashN/A65.8538.1834.62Price / Book0.466.516.774.25Net Income-$27.24M$143.21M$3.22B$248.23M7 Day Performance-2.06%1.98%1.48%0.89%1 Month Performance54.69%6.89%3.99%3.53%1 Year Performance-2.81%-2.52%16.20%5.08% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.3656 of 5 stars$0.76-10.7%$5.00+557.9%+6.7%$21.17M$11.71M-2.2450Short Interest ↑Gap DownBMEABiomea Fusion3.284 of 5 stars$1.72+1.8%$23.91+1,290.1%-80.4%$64.62MN/A-0.4350Upcoming EarningsNews CoveragePositive NewsABOSAcumen Pharmaceuticals2.4285 of 5 stars$1.06+17.7%$7.33+591.8%-64.9%$64.21MN/A-0.7720Positive NewsGap DownRENBRenovaro1.227 of 5 stars$0.40+13.9%N/A-77.2%$63.76MN/A-0.4320Positive NewsINZYInozyme Pharma2.967 of 5 stars$0.98+6.5%$14.63+1,393.3%-73.9%$62.92MN/A-0.6350Upcoming EarningsNews CoveragePositive NewsGap DownVTVTvTv Therapeutics1.7483 of 5 stars$19.67-0.2%$35.50+80.5%-28.5%$62.75M$1.02M-4.349Short Interest ↑Gap DownRANIRani Therapeutics2.4646 of 5 stars$1.09-6.8%$12.33+1,031.5%-82.6%$62.66M$1.03M-1.03110Upcoming EarningsGap DownANROAlto Neuroscience1.8393 of 5 stars$2.31+2.2%$15.40+566.7%-84.1%$62.54MN/A-0.91N/AMGXMetagenomi1.3478 of 5 stars$1.67+9.9%$13.00+678.4%-75.4%$62.43M$52.30M-0.64236News CoveragePositive NewsADAPAdaptimmune Therapeutics3.4149 of 5 stars$0.24+1.7%$1.83+655.6%-76.7%$62.30M$178.03M-1.10490Analyst ForecastShort Interest ↓Positive NewsVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading Volume Related Companies and Tools Related Companies Biomea Fusion Alternatives Acumen Pharmaceuticals Alternatives Renovaro Alternatives Inozyme Pharma Alternatives vTv Therapeutics Alternatives Rani Therapeutics Alternatives Alto Neuroscience Alternatives Metagenomi Alternatives Adaptimmune Therapeutics Alternatives Viveon Health Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLGL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLGL Stock Free SLGL Stock Alerts